Table 2.
Association between antibiotics, drug resistance patterns and phage susceptibility.
| Antibiotics/drug resistance patterns | No. of phage susceptible isolates | p-values* | |
|---|---|---|---|
| Drug resistant | Drug susceptible | ||
| Antibiotics | |||
| Amikacin (AK) | 80/123 (65.04%) | 27/107 (25.23%) | < 0.001 |
| Ciprofloxacin (CIP) | 104/196 (53.06%) | 3/34 (8.82%) | < 0.001 |
| Trimethoprim/sulfamethoxazole (SXT) | 75/151 (49.67%) | 32/79 (40.51%) | 0.1859 |
| Cefotaxime (CTX) | 96/185 (51.89%) | 11/45 (24.44%) | 0.0009 |
| Ceftazidime (CAZ) | 100/191 (52.35%) | 7/39 (17.95%) | 0.0001 |
| Cefoperazone/sulbactam (CSL) | 38/66 (57.57%) | 69/164 (42.07%) | 0.0330 |
| Imipenem (IPM) | 103/189 (54.49%) | 4/41 (9.76%) | < 0.001 |
| Meropenem (MEM) | 104/188 (55.32%) | 3/42 (7.14%) | < 0.001 |
| Piperacillin/tazobactam (PIP) | 101/190 (53.16%) | 6/40 (15.00%) | < 0.001 |
| Tetracycline (TE) | 89/142 (62.67%) | 18/88 (20.45%) | < 0.001 |
| Ceftriaxone (CRO) | 101/193(52.33%) | 6/37 (16.22%) | 0.0001 |
| Cefepime (FEP) | 89/170 (52.35%) | 18/60 (30.00%) | 0.0028 |
| Gentamicin (CN) | 83/146 (56.85%) | 24/84 (28.57%) | < 0.001 |
| Drug resistance patterns | |||
| MDR-AB | 105/199 (52.76%) | 2/31 (6.45%) | < 0.001 |
| CR-AB | 103/192 (53.64%) | 4/38 (10.53%) | < 0.001 |
| XDR-AB | 20/28 (71.43%) | 87/202 (43.07%) | 0.0048 |
| Non MDR-AB | 2/28 (7.14%) | 105/202 (51.98%) | < 0.001 |
*p-values less than 0.05 were considered as a statistically significant difference (Fisher's exact test). Bold font indicates statistically significant difference between two groups.